Hanoglu, Lutfu

Multi-omics characterization of improved cognitive functions in Parkinson's disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial

Multi-omics analysis reveals the key factors involved in the severity of the Alzheimer's disease

Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases (Retraction of Vol 314, art no 121325, 2023)

Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases

Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial